keyword
https://read.qxmd.com/read/38655839/nir-fluorescent-photoacoustic-bimodal-imaging-of-ferroptosis-in-pancreatic-cancer-using-biothiols-activable-probes
#1
JOURNAL ARTICLE
Lingyun Li, Zhipengjun Zhang, Lei Zhou, Haifeng Ge, Yixing Zhao, Yijun Gong, Guo-Jiang Mao, Hongwen Liu
Ferroptosis modulation is a powerful therapeutic option for pancreatic ductal adenocarcinoma (PDAC) with a low 5-year survival rate and lack of effective treatment methods. However, due to the dual role of ferroptosis in promoting and inhibiting pancreatic tumorigenesis, regulating the degree of ferroptosis is very important to obtain the best therapeutic effect of PDAC. Biothiols are suitable as biomarkers of imaging ferroptosis due to the dramatic decreases of biothiol levels in ferroptosis caused by the inhibited synthesis pathway of glutathione (GSH) and the depletion of biothiol by reactive oxygen species...
April 24, 2024: Analytical Chemistry
https://read.qxmd.com/read/38650074/computed-tomographic-features-of-exocrine-pancreatic-carcinomas-in-dogs-and-cats
#2
JOURNAL ARTICLE
Alexandra Dunn, Sangeeta Rao, Brian Husbands, Nicholas Petrovitch, Samantha Loeber, Tobias Schwarz, Kelsey Cline, Wilfried Mai, Heather Spain, Kaitlin Curran, Kate Vickery, Angela Marolf
Exocrine pancreatic carcinomas are uncommon in dogs and cats, and diagnosis with diagnostic imaging can be challenging. This retrospective, multi-institutional, descriptive study was performed to evaluate the CT features of exocrine pancreatic carcinomas. The CT examinations of 18 dogs and 12 cats with exocrine pancreatic carcinomas diagnosed by cytology or histopathology were reviewed. The CT features of exocrine pancreatic carcinomas included a well-defined mass in 28/30 (93%) with contrast enhancement in 27/30 (90%), commonly heterogeneous 22/30 (73%); often with a nonenhancing fluid to soft tissue attenuating center 12/30 (40%)...
April 22, 2024: Veterinary Radiology & Ultrasound
https://read.qxmd.com/read/38646386/advancements-in-pancreatic-cancer-detection-integrating-biomarkers-imaging-technologies-and-machine-learning-for-early-diagnosis
#3
REVIEW
Hisham Daher, Sneha A Punchayil, Amro Ahmed Elbeltagi Ismail, Reuben Ryan Fernandes, Joel Jacob, Mohab H Algazzar, Mohammad Mansour
Artificial intelligence (AI) has come to play a pivotal role in revolutionizing medical practices, particularly in the field of pancreatic cancer detection and management. As a leading cause of cancer-related deaths, pancreatic cancer warrants innovative approaches due to its typically advanced stage at diagnosis and dismal survival rates. Present detection methods, constrained by limitations in accuracy and efficiency, underscore the necessity for novel solutions. AI-driven methodologies present promising avenues for enhancing early detection and prognosis forecasting...
March 2024: Curēus
https://read.qxmd.com/read/38641714/combined-yet-separate-cocktails-of-carriers-not-drugs-for-actinium-225-%C3%AE-particle-therapy-of-solid-tumors-expressing-moderate-to-low-levels-of-targetable-markers
#4
JOURNAL ARTICLE
Rajiv Ranjit Nair, Aprameya Prasad, Omkar Bhatavdekar, Aira Sarkar, Kathleen L Gabrielson, Stavroula Sofou
UNLABELLED: Alpha-particle radionuclide-antibody conjugates are being clinically evaluated against solid tumors even when they moderately express the targeted markers. At this limit of lower tumor-absorbed doses, to maintain efficacy, the few(er) intratumorally delivered alpha-particles need to traverse/hit as many different cancer cells as possible. We complement antibody-radioconjugate therapies with a separate nanocarrier delivering a fraction of the same total injected radioactivity to tumor regions geographically different than those affected by targeting antibodies; these carrier-cocktails collectively distribute the alpha-particle emitters better...
April 20, 2024: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38639911/quantitative-mr-imaging-biomarkers-for-distinguishing-inflammatory-pancreatic-mass-and-pancreatic-cancer-a-systematic-review-and-meta-analysis
#5
REVIEW
Zi-He Wang, Liang Zhu, Hua-Dan Xue, Zheng-Yu Jin
OBJECTIVES: To evaluate the diagnostic performance of quantitative magnetic resonance (MR) imaging biomarkers in distinguishing between inflammatory pancreatic masses (IPM) and pancreatic cancer (PC). METHODS: A literature search was conducted using PubMed, Embase, the Cochrane Library, and Web of Science through August 2023. Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) was used to evaluate the risk of bias and applicability of the studies. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were calculated using the DerSimonian-Laird method...
April 19, 2024: European Radiology
https://read.qxmd.com/read/38639585/advances-in-tumor-management-harnessing-the-potential-of-histotripsy
#6
REVIEW
Yash Verma, Arosh S Perera Molligoda Arachchige
Tissue ablation techniques have long been used in clinical settings to treat various oncologic diseases. However, many of these techniques are invasive and can cause substantial adverse effects. Histotripsy is a noninvasive, nonionizing, nonthermal tissue ablation technique that has the potential to replace surgical interventions in various clinical settings. Histotripsy works by delivering high-intensity focused ultrasound waves to target tissue. These waves create cavitation bubbles within tissues that rapidly expand and collapse, thereby mechanically fractionating the tissue into acellular debris that is subsequently absorbed by the body's immune system...
May 2024: Radiology. Imaging cancer
https://read.qxmd.com/read/38636183/role-of-diagnostic-laparoscopy-during-pancreatic-cancer-surgery-in-the-modern-era
#7
JOURNAL ARTICLE
Jeremy Chang, Scott K Sherman, James P De Andrade, Hisakazu Hoshi, James R Howe, Carlos H F Chan
INTRODUCTION: Despite improvements in preoperative image resolution, approximately 10% of curative-intent resection attempts for pancreatic ductal adenocarcinoma are aborted at the time of operation. To avoid nontherapeutic laparotomy, many surgeons perform intraoperative diagnostic laparoscopy (DL) to identify radiographically occult metastatic disease. There are no consensus guidelines regarding DL in pancreatic cancer. The goal of this study is to investigate the efficacy of same-procedure DL at avoiding nontherapeutic laparotomy...
April 17, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38634790/blood-based-multiomics-guided-detection-of-a-precancerous-pancreatic-tumor
#8
JOURNAL ARTICLE
Mohammad A Anwar, Ammar H Keshteli, Haiyan Yang, Windy Wang, Xukun Li, Helen M Messier, Pieter R Cullis, Christoph H Borchers, Robert Fraser, David S Wishart
Over a decade ago, longitudinal multiomics analysis was pioneered for early disease detection and individually tailored precision health interventions. However, high sample processing costs, expansive multiomics measurements along with complex data analysis have made this approach to precision/personalized medicine impractical. Here we describe in a case report, a more practical approach that uses fewer measurements, annual sampling, and faster decision making. We also show how this approach offers promise to detect an exceedingly rare and potentially fatal condition before it fully manifests...
April 17, 2024: Omics: a Journal of Integrative Biology
https://read.qxmd.com/read/38630314/inter-reader-agreement-of-pancreatic-adenocarcinoma-resectability-assessment-with-photon-counting-versus-energy-integrating-detector-ct
#9
JOURNAL ARTICLE
Jesi Kim, Tarub Mabud, Chenchan Huang, Juan Lloret Del Hoyo, Robert Petrocelli, Abhinav Vij, Bari Dane
PURPOSE: To compare the inter-reader agreement of pancreatic adenocarcinoma resectability assessment at pancreatic protocol photon-counting CT (PCCT) with conventional energy-integrating detector CT (EID-CT). METHODS: A retrospective single institution database search identified all contrast-enhanced pancreatic mass protocol abdominal CT performed at an outpatient facility with both a PCCT and EID-CT from 4/11/2022 to 10/30/2022. Patients without pancreatic adenocarcinoma were excluded...
April 17, 2024: Abdominal Radiology
https://read.qxmd.com/read/38628808/two-cases-of-a-portal-annular-pancreas-in-patients-undergoing-pancreaticoduodenectomy
#10
Mineto Ohta, Keisuke Fukushima, Hiroyasu Nishimaki, Takayuki Morita, Yuta Ito, Kenji Namiki
INTRODUCTION: Portal annular pancreas (PAP) is a congenital anomaly resulting from aberrant fusion of the ventral and dorsal pancreatic buds around the portal vein (PV). PAP was classified into three types by Joseph et al., based on the location of the main pancreatic duct around the PV. The presence of PAP is important for the surgical procedure because it is associated with the postoperative pancreatic fistula. There are no standardized surgical procedures of resection and reconstruction for PAP...
2024: Case Reports in Gastroenterology
https://read.qxmd.com/read/38628502/feasibility-of-comprehensive-genomic-profiling-using-endoscopic-ultrasound-guided-tissue-acquisition-with-a-22-gauge-franseen-needle
#11
JOURNAL ARTICLE
Kazunaga Ishigaki, Yousuke Nakai, Go Endo, Kohei Kurihara, Kota Ishida, Shuichi Tange, Rintaro Fukuda, Shinya Takaoka, Yurie Tokito, Yukari Suzuki, Hiroki Oyama, Sachiko Kanai, Tatsunori Suzuki, Tatsuya Sato, Ryunosuke Hakuta, Tomotaka Saito, Tsuyoshi Hamada, Naminatsu Takahara, Aya Shinozaki-Ushiku, Mitsuhiro Fujishiro
AIM: Comprehensive genomic profiling (CGP) test for solid tumors is now increasingly utilized in clinical practice, especially in pancreatobiliary cancer, and specimens obtained by endoscopic ultrasound-guided tissue acquisition (EUS-TA) are often submitted for tissue-based CGP test. In this study, we evaluated the feasibility of EUS-TA using a 22-gauge Franseen needle for the CGP test. METHODS: Consecutive patients with solid tumors who underwent EUS-TA using a 22-gauge Franseen needle, and whose tissue samples were pre-checked for suitability for CGP test, were included in this single-center, retrospective analysis...
April 2024:
https://read.qxmd.com/read/38627014/acquisition-duration-optimization-using-visual-grading-regression-in-68-ga-fapi-46-pet-imaging-of-oncologic-patients
#12
JOURNAL ARTICLE
Ted Nilsson, Pawel Rasinski, Örjan Smedby, Siri Af Burén, Ernesto Sparrelid, J Matthias Löhr, Thuy A Tran, August Blomgren, Antonios Tzortzakakis, Rimma Axelsson, Maria Holstensson
Fibroblast activation protein is a promising target for oncologic molecular imaging with radiolabeled fibroblast activation protein inhibitors (FAPI) in a large variety of cancers. However, there are yet no published recommendations on how to set up an optimal imaging protocol for FAPI PET/CT. It is important to optimize the acquisition duration and strive toward an acquisition that is sufficiently short while simultaneously providing sufficient image quality to ensure a reliable diagnosis. The aim of this study was to evaluate the feasibility of reducing the acquisition duration of [68 Ga]FAPI-46 imaging while maintaining satisfactory image quality, with certainty that the radiologist's ability to make a clinical diagnosis would not be affected...
April 16, 2024: Journal of Nuclear Medicine Technology
https://read.qxmd.com/read/38626807/the-pancreatic-cancer-early-detection-precede-study-is-a-global-effort-to-drive-early-detection-baseline-imaging-findings-in-high-risk-individuals
#13
JOURNAL ARTICLE
George Zogopoulos, Ido Haimi, Shenin A Sanoba, Jessica N Everett, Yifan Wang, Bryson W Katona, James J Farrell, Aaron J Grossberg, Salvatore Paiella, Kelsey A Klute, Yan Bi, Michael B Wallace, Richard S Kwon, Elena M Stoffel, Raymond C Wadlow, Daniel A Sussman, Nipun B Merchant, Jennifer B Permuth, Talia Golan, Maria Raitses-Gurevich, Andrew M Lowy, Joy Liau, Joanne M Jeter, James M Lindberg, Daniel C Chung, Julie Earl, Teresa A Brentnall, Kasmintan A Schrader, Vivek Kaul, Chenchan Huang, Hersh Chandarana, Caroline Smerdon, John J Graff, Fay Kastrinos, Sonia S Kupfer, Aimee L Lucas, Rosalie C Sears, Randall E Brand, Giovanni Parmigiani, Diane M Simeone
BACKGROUND: Pancreatic adenocarcinoma (PC) is a highly lethal malignancy with a survival rate of only 12%. Surveillance is recommended for high-risk individuals (HRIs), but it is not widely adopted. To address this unmet clinical need and drive early diagnosis research, we established the Pancreatic Cancer Early Detection (PRECEDE) Consortium. METHODS: PRECEDE is a multi-institutional international collaboration that has undertaken an observational prospective cohort study...
April 2024: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/38623128/clinical-significance-and-resource-burden-of-double-duct-sign-in-non-jaundiced-patients
#14
JOURNAL ARTICLE
Ahmed Mahmoud Askar, Wajith Hussain Zahir Hussain, Rishi Chavda, Wen Chung, Eyad Issa, John Isherwood, Ashley Dennison, Giuseppe Garcea
Aim The study aims to determine the incidence of malignancy at presentation and subsequent risk of malignancy (at 12 months follow-up) in a cohort of patients with double duct sign (DDS) on cross-sectional imaging but no visible stigmata of jaundice. The study also correlates malignancy with liver enzyme dysfunction and estimates the resource burden incurred during the investigation of these patients. Methods A search for the key term "double duct sign" was undertaken in the radiological database of a tertiary hepatopancreatobiliary (HPB) centre between March 2017 and March 2022...
March 2024: Curēus
https://read.qxmd.com/read/38618326/trousseau-s-syndrome-with-severe-visual-loss-as-the-initial-symptom
#15
Atsushi Okubo, Ryo Obata, Keiko Azuma, Shuichi Kishimoto, Mikiro Mori
There are limited reports on patients with Trousseau syndrome, a condition characterized by hypercoagulability associated with malignant tumors, initially manifesting with reduced visual function. We present a case of a patient who experienced bilateral vision loss and was subsequently diagnosed with Trousseau's syndrome following examination and investigations. A 70-year-old man, undergoing chemotherapy for advanced pancreatic cancer, reported decreased visual acuity in both eyes. A dilated fundus examination revealed retinal pigment epithelial atrophy in the posterior pole and cotton-wool spots...
March 2024: Curēus
https://read.qxmd.com/read/38617474/glutamatergic-neurons-in-the-paraventricular-nucleus-of-the-hypothalamus-participate-in-the-regulation-of-visceral-pain-induced-by-pancreatic-cancer-in-mice
#16
JOURNAL ARTICLE
Ning-Ning Ji, Shuang Cao, Xing-Lei Song, Bei Pei, Chen-Yu Jin, Bi-Fa Fan, Hong Jiang, Ming Xia
BACKGROUND: Visceral pain induced by pancreatic cancer seriously affects patients' quality of life, and there is no effective treatment, because the mechanism of its neural circuit is unknown. Therefore, the aim of this study is to explore the main neural circuit mechanism regulating visceral pain induced by pancreatic cancer in mice. METHODS: The mouse model of pancreatic cancer visceral pain was established on C57BL/6N mice by pancreatic injection of mPAKPC-luc cells...
April 3, 2024: Hepatobiliary Surgery and Nutrition
https://read.qxmd.com/read/38614983/the-preliminary-analysis-of-lymphatic-flow-around-the-connective-tissues-surrounding-sma-and-spa-elucidates-patients-oncological-condition-in-borderline-resectable-pancreatic-cancer
#17
JOURNAL ARTICLE
Hirofumi Akita, Kei Asukai, Yosuke Mukai, Shinichiro Hasegawa, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue, Masato Sakon, Hiroshi Wada, Hidenori Takahashi
BACKGROUND: In pancreatic ductal adenocarcinoma (PDAC), invasion of connective tissues surrounding major arteries is a crucial prognostic factor after radical resection. However, why the connective tissues invasion is associated with poor prognosis is not well understood. MATERIALS AND METHODS: From 2018 to 2020, 25 patients receiving radical surgery for PDAC in our institute were enrolled. HyperEye Medical System (HEMS) was used to examine lymphatic flow from the connective tissues surrounding SMA and SpA and which lymph nodes ICG accumulated in was examined...
April 13, 2024: BMC Surgery
https://read.qxmd.com/read/38611692/the-doppler-perfusion-index-of-the-liver-and-the-underlying-duplex-sonography-of-visceral-vessels-a-systematic-and-comprehensive-evaluation-of-reproducibility
#18
JOURNAL ARTICLE
Christian Lueders, Johannes Gladitz, Georg Bauer, Christian Jenssen, Jana Belaschki, Arndt von Kirchbach, Christoph Schneider, Thomas Kiefer, Heinz Voeller, Daniel Merkel
Prior to the curative resection of colorectal carcinoma (CRC) or pancreatic ductal adenocarcinoma (PDAC), the exclusion of hepatic metastasis using cross-sectional imaging is mandatory. The Doppler perfusion index (DPI) of the liver is a promising method for detecting occult liver metastases, but the underlying visceral duplex sonography is critically viewed in terms of its reproducibility. The aim of this study was to investigate systematically the reproducibility of the measured variables, the calculated blood flow, and the DPI...
April 8, 2024: Diagnostics
https://read.qxmd.com/read/38611638/three-dimensional-structure-of-novel-liver-cancer-biomarker-liver-cancer-specific-serine-protease-inhibitor-kazal-lc-spik-and-its-performance-in-clinical-diagnosis-of-hepatocellular-carcinoma-hcc
#19
REVIEW
Felix Lu, Connor Ott, Prabha Bista, Xuanyong Lu
LC-SPIK is a liver cancer-specific isoform of Serine Protease Inhibitor Kazal and has been proposed as a new biomarker for the detection of HCC given its unique 3D structure, which differs from normal pancreatic SPIK. An ELISA technology based on its unique structure was developed to use LC-SPIK as an effective biomarker for the clinical diagnosis of HCC. AFP, the most widely used biomarker for HCC surveillance currently, suffers from poor clinical performance, especially in the detection of early-stage HCC...
March 29, 2024: Diagnostics
https://read.qxmd.com/read/38610923/enhancing-image-guided-radiation-therapy-for-pancreatic-cancer-utilizing-aligned-peak-response-beamforming-in-flexible-array-transducers
#20
JOURNAL ARTICLE
Ziwei Feng, Edward Sun, Debarghya China, Xinyue Huang, Hamed Hooshangnejad, Eduardo A Gonzalez, Muyinatu A Lediju Bell, Kai Ding
To develop ultrasound-guided radiotherapy, we proposed an assistant structure with embedded markers along with a novel alternative method, the Aligned Peak Response (APR) method, to alter the conventional delay-and-sum (DAS) beamformer for reconstructing ultrasound images obtained from a flexible array. We simulated imaging targets in Field-II using point target phantoms with point targets at different locations. In the experimental phantom ultrasound images, image RF data were acquired with a flexible transducer with in-house assistant structures embedded with needle targets for testing the accuracy of the APR method...
March 22, 2024: Cancers
keyword
keyword
38631
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.